Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer
Clinical trial NCT02591784 · COMPLETED
Trial details
- NCT number
- NCT02591784
- Sponsor
- Biotech Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2011-12-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.